(1) The manufacturer is responsible for the actions and conduct of its representatives with regard to drug samples.
(2) The commission may hold a public hearing to examine a possible violation and may require a designated representative of the manufacturer to attend.
(3) If a manufacturer fails to comply with this chapter following notification by the commission, the commission may impose a civil penalty of up to five thousand dollars. The commission shall take no action to impose any civil penalty except pursuant to a hearing held in accordance with chapter 34.05 RCW.
(4) Specific drug samples which are distributed in this state in violation of this chapter, following notification by the commission, shall be subject to seizure following the procedures set out in RCW 69.41.060.
[ 2013 c 19 § 84; 1987 c 411 § 8.]